Avenue Therapeutics Inc. (ATXI)
Avenue Therapeutics Statistics
Share Statistics
Avenue Therapeutics has 3.15M shares outstanding. The number of shares has increased by 118.27% in one year.
| Shares Outstanding | 3.15M |
| Shares Change (YoY) | 118.27% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 1.12% |
| Shares Floating | 2.8M |
| Failed to Deliver (FTD) Shares | 667 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 59.7K, so 1.9% of the outstanding shares have been sold short.
| Short Interest | 59.7K |
| Short % of Shares Out | 1.9% |
| Short % of Float | 2.13% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.22 and the forward PE ratio is -0.14. Avenue Therapeutics's PEG ratio is 0.02.
| PE Ratio | -2.22 |
| Forward PE | -0.14 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 9.26 |
| P/FCF Ratio | -2.87 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Avenue Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.
| Current Ratio | 3.27 |
| Quick Ratio | 3.27 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-5.83M |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -97.53% in the last 52 weeks. The beta is 0.1, so Avenue Therapeutics's price volatility has been higher than the market average.
| Beta | 0.1 |
| 52-Week Price Change | -97.53% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 19.23 |
| Average Volume (20 Days) | 414.97K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -11.28M |
| Net Income | -11.65M |
| EBITDA | -11.28M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.9 |
Balance Sheet
The company has 2.59M in cash and 0 in debt, giving a net cash position of 2.59M.
| Cash & Cash Equivalents | 2.59M |
| Total Debt | 0 |
| Net Cash | 2.59M |
| Retained Earnings | -102.58M |
| Total Assets | 2.67M |
| Working Capital | 1.86M |
Cash Flow
In the last 12 months, operating cash flow was -9.03M and capital expenditures 0, giving a free cash flow of -9.03M.
| Operating Cash Flow | -9.03M |
| Capital Expenditures | 0 |
| Free Cash Flow | -9.03M |
| FCF Per Share | -0.7 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ATXI.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 26, 2024. It was a backward split with a ratio of 1:75.
| Last Split Date | Apr 26, 2024 |
| Split Type | backward |
| Split Ratio | 1:75 |
Scores
| Altman Z-Score | -66.21 |
| Piotroski F-Score | 3 |